Company intelligence / Profile preview

Junson Capital

Ownership
Private
Development stage
Other
01

Overview

Junson Capital is a Hong Kong-based global investment management firm specializing in real estate, private equity—including direct investments into life science/biotech—and capital markets. The firm manages over $5 billion in assets and has made at least 14 direct investments across healthcare and biotechnology sectors globally. It is known for its strategic focus on high-growth opportunities within the US, China, Europe, and Asia-Pacific regions. Recent notable investments include Full-Life Technologies (radiopharmaceuticals), Corsair Pharma (ophthalmology), Allotex (corneal tissue engineering), Worg Pharmaceuticals (allergy immunotherapy), MabPlex International (CDMO services), among others.

Therapeutic areas
ImmunologyOncologyOphthalmology
Modalities
Monoclonal antibodySmall moleculeBiologicGene therapyRadiopharmaceuticalTissue engineering/device
Industry
Investors
02

Partnerships

No major disclosed pharmaceutical or biotech partnerships; acts primarily as an independent financial investor/co-investor alongside other VCs/funds.

Beyond the preview

Go deeper on Junson Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Junson Capital.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call